[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fNmOaHonTYhJ3O-yq2_WS3iLUGNoZMzWNByrxvR36efc":8,"$fuGXOU8YxUmYpQhorOchSrY260MsAAlt53OuDOCMQsRc":55,"$fFZXLrZqdShTuHGG8lMdhiXSmX_rtzDChR9XT4iaVfv0":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},66115,867529,[],"https://ystcdn.venuertc.com/learnMaterial/ystApp//9SQe9lagz4wfiZ4xbL7sJDWJjVGvm6Hg.png","王近瑜","湖州市中心医院","呼吸内科","主治医师",152,0,"肺癌治疗新技术：靶向药与免疫药的安全用药指南","","https://ystcdn.venuertc.com/venue/AI/9d78f082-eeca-4d82-b2cf-cf480197caa4.jpg","\u003Cdiv class=\"anti-cancer-guide-root\">\n  \u003Cdiv class=\"anti-cancer-guide-banner\">\n    \u003Ch2 id=\"material_title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">肺癌治疗新技术：靶向药与免疫药的安全用药指南\u003C/h2>\n    \u003Cdiv class=\"anti-cancer-guide-lead\">\n      \u003Cspan>🌿\u003C/span>\n      \u003Cspan>现代肺癌治疗不再只有化疗，靶向药与免疫药逐渐成为新选择。很多朋友对这些药物的服用方法和安全细节还不够熟悉。今天，这篇使用指南将带你了解7个关键点，助你规避用药风险，把握正确用法，放心配合治疗。\u003C/span>\n    \u003C/div>\n  \u003C/div>\n\n  \u003C!-- 作用机制 -->\n  \u003Csection class=\"anti-cancer-guide-section\" style=\"background:linear-gradient(90deg, #f3f7fa 60%, #e9f4ee 100%);\">\n    \u003Ch2 class=\"anti-cancer-guide-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n      01 作用机制速览：靶向药与免疫药怎么起作用？🔬\n    \u003C/h2>\n    \u003Cdiv class=\"anti-cancer-guide-text\">\n      靶向药（如阿来替尼、伏美替尼、贝伐珠单抗）通过精准抑制肿瘤细胞的异常信号通路或供血，从而抑制癌细胞生长和扩散。\u003Cbr>\n      \u003Cb>举个例子：\u003C/b>阿来替尼主要针对ALK基因异常，阻断其信号传导过程。伏美替尼则作用于EGFR（表皮生长因子受体）突变。贝伐珠单抗属于抗血管生成药，干扰肿瘤微血管养分通路。\u003Cbr>\n      免疫药（如信迪利单抗）属于PD-1抑制剂，它通过激活人体免疫细胞识别并清除肿瘤细胞，让“身体警察”发挥本能。\u003Cbr>\n      \u003Cspan class=\"anti-cancer-guide-remark\">正确做法：\u003C/span>了解自己的靶点（如ALK、EGFR）和用药类型，对症选药，执行医生指导。\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 服用时间与用法要点 -->\n  \u003Csection class=\"anti-cancer-guide-section\" style=\"background:linear-gradient(90deg, #f7f6fd 60%, #eef2f6 100%);\">\n    \u003Ch2 class=\"anti-cancer-guide-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n      02 给药时机与方法：怎么吃/输用才最有效？⏰\n    \u003C/h2>\n    \u003Cdiv class=\"anti-cancer-guide-text\">\n      靶向药大多为口服，免疫药多需静脉点滴。服用时间、方式有讲究——\n      \u003Cul class=\"anti-cancer-guide-list\">\n        \u003Cli>\u003Cb>阿来替尼、伏美替尼：\u003C/b>建议餐前或餐后均可服用，以全片吞服为宜。不推荐掰碎或研粉，避免药效波动。\u003C/li>\n        \u003Cli>\u003Cb>贝伐珠单抗、信迪利单抗：\u003C/b>只可在医院静脉输注，不可自行注射，输注时须观察有无过敏等急性反应。\u003C/li>\n      \u003C/ul>\n      \u003Cspan class=\"anti-cancer-guide-remark\">正确做法：\u003C/span>按说明书或医嘱准时服用，每日同一时间服药有助于建立习惯，避免漏服。\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 剂型特点与服用技巧 -->\n  \u003Csection class=\"anti-cancer-guide-section\" style=\"background:linear-gradient(90deg, #f9f3ed 60%, #f6f6eb 100%);\">\n    \u003Ch2 class=\"anti-cancer-guide-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n      03 剂型和服用技巧：片剂、注射剂的区别 🧴\n    \u003C/h2>\n    \u003Cdiv class=\"anti-cancer-guide-text\">\n      \u003Cul class=\"anti-cancer-guide-list\">\n        \u003Cli>\n          \u003Cb>片剂/胶囊：\u003C/b>需用水整片吞服，部分药品（如阿来替尼胶囊）因肠溶衣不同，不能掰开或嚼碎，避免肠胃道刺激或药效丧失。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>注射剂：\u003C/b>如贝伐珠单抗、信迪利单抗，仅限静脉滴注，操作需由医护人员完成。输液时需监测生命体征，预防过敏等突发反应。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cspan class=\"anti-cancer-guide-remark\">需要注意：\u003C/span>如有吞咽困难情况，要提前告知医师，不可自行处理药物外观！\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 剂量调整与特殊人群 -->\n  \u003Csection class=\"anti-cancer-guide-section\" style=\"background:linear-gradient(90deg, #eef6f8 60%, #f6f3f9 100%);\">\n    \u003Ch2 class=\"anti-cancer-guide-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n      04 剂量调整与特殊人群：哪些情况下要慎用？👵\n    \u003C/h2>\n    \u003Cdiv class=\"anti-cancer-guide-text\">\n      靶向药和免疫药的剂量通常需根据体重、肝肾功能和耐受情况个体化调整：\n      \u003Cul class=\"anti-cancer-guide-list\">\n        \u003Cli>\n          老年患者、体重偏低者、合并慢性病的人，常需调整剂量或延长给药间隔。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>肝肾功能异常：\u003C/b>因为药物主要在肝肾代谢，有损害时药物可能累积，风险加大。需减量或延长间隔，务必听从医师调整。\n        \u003C/li>\n        \u003Cli>\n          孕妇、哺乳期妇女原则上禁用此类药品（详见禁忌症部分）。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cspan class=\"anti-cancer-guide-remark\">案例：\u003C/span>一位67岁男性长期用药期间，因化疗后骨髓抑制出现耐受不良反应，医生及时调整剂量，有效改善用药安全性。\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 药物相互作用防护要点 -->\n  \u003Csection class=\"anti-cancer-guide-section\" style=\"background:linear-gradient(90deg, #f6f9f4 60%, #eff2f5 100%);\">\n    \u003Ch2 class=\"anti-cancer-guide-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n      05 药物相互作用：你必须规避的“雷区”💊\n    \u003C/h2>\n    \u003Cdiv class=\"anti-cancer-guide-text\">\n      靶向药和免疫药容易与其他药品“打架”，影响疗效或加重副作用。\n      \u003Cul class=\"anti-cancer-guide-list\">\n        \u003Cli>\n          \u003Cb>阿来替尼、伏美替尼：\u003C/b>禁与强效CYP3A4抑制或诱导药物同服（如某些抗生素、抗真菌药、抗癫痫药），否则血药浓度易升高或降低。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>贝伐珠单抗：\u003C/b>与抗凝药、抗血小板药同用，出血风险增加，不建议擅自叠加使用其他止血、降压药品。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>信迪利单抗：\u003C/b>慎与免疫抑制剂或激素并用，否则会抵消其免疫激活作用。\n        \u003C/li>\n        \u003Cli>\n          靶向药若与抑酸药（如泮托拉唑）同用，建议间隔2小时，避免影响吸收。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cspan class=\"anti-cancer-guide-remark\">正确做法：\u003C/span>每次就诊时如实告知已用药物，遇新药需咨询医生有无冲突后才加入用药方案。\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 不良反应及处理方法 -->\n  \u003Csection class=\"anti-cancer-guide-section\" style=\"background:linear-gradient(90deg, #faf3f6 60%, #ecf4f7 100%);\">\n    \u003Ch2 class=\"anti-cancer-guide-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n      06 常见不良反应：如何识别和应对？⚠️\n    \u003C/h2>\n    \u003Cdiv class=\"anti-cancer-guide-text\">\n      临床研究提示，靶向和免疫药的不良反应各有侧重——\n      \u003Cul class=\"anti-cancer-guide-list\">\n        \u003Cli>\n          \u003Cb>阿来替尼、伏美替尼：\u003C/b>常见腹泻、恶心、皮疹、肝功能异常，个别可能有肌酐升高、光敏反应。长期服用还需警惕间质性肺病等罕见不良反应。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>贝伐珠单抗：\u003C/b>易引起高血压、蛋白尿、出血、伤口愈合变慢等，部分人有静脉栓塞风险。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>信迪利单抗：\u003C/b>免疫相关副作用为主，如皮疹、肠炎、内分泌变化。需定期抽血检查肝肾、甲功。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cspan class=\"anti-cancer-guide-remark\">处理方法：\u003C/span>出现不良反应时，不可擅自停药，应及时告知医生，必要时调整剂量或联合其他药物缓解症状。出现高热、严重皮疹、持续呕吐等“红色警示”现象应立即就医。\n      \u003Cbr>\n      \u003Cspan>临床数据：\u003C/span> 一项关于阿来替尼的3期临床研究显示，Ⅲ度以上不良反应整体发生率约在40%左右（Shaw AT, et al. N Engl J Med. 2014）。\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 储存方法＆过期处理 -->\n  \u003Csection class=\"anti-cancer-guide-section\" style=\"background:linear-gradient(90deg, #f5faf8 60%, #f2f5f9 100%);\">\n    \u003Ch2 class=\"anti-cancer-guide-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n      07 储存方法与过期处理：药品保管“三要点”🗃️\n    \u003C/h2>\n    \u003Cdiv class=\"anti-cancer-guide-text\">\n      正确储存可防止药物变质失效：\n      \u003Cul class=\"anti-cancer-guide-list\">\n        \u003Cli>\n          \u003Cb>环境：\u003C/b>大部分片剂、胶囊建议避光、避潮，常温（15~30℃）保存，不可放入冰箱冷冻层。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>开瓶后：\u003C/b>应密封保存，远离小孩宠物。部分注射剂如开封后应一次用完，不可存放。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>过期药品：\u003C/b>丢入专用回收箱，不建议直接丢入生活垃圾桶，避免环境污染及误服风险。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cspan class=\"anti-cancer-guide-remark\">特别提醒：\u003C/span>如发现药品塑封脱落、变色、气味异常，切勿继续使用！\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 漏服/过量处理要点 -->\n  \u003Csection class=\"anti-cancer-guide-section\" style=\"background:linear-gradient(90deg, #fbf6f1 60%, #f3f7f8 100%);\">\n    \u003Ch2 class=\"anti-cancer-guide-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n      08 漏服与过量处理：遇到意外怎么办？🔑\n    \u003C/h2>\n    \u003Cdiv class=\"anti-cancer-guide-text\">\n      \u003Cul class=\"anti-cancer-guide-list\">\n        \u003Cli>\n          \u003Cb>漏服：\u003C/b>发现后尽快补服；如果接近下次服药时间，则跳过该次，不宜一次双倍剂量。\n        \u003C/li>\n        \u003Cli>\n          \u003Cb>过量服用：\u003C/b>不可自行处理，须立刻携带药品包装前往医院，便于医生紧急处置。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cspan class=\"anti-cancer-guide-remark\">正确做法：\u003C/span>每日设定定时提醒，养成规律用药习惯，可有效预防漏服和重复服药风险。\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 总结与用药建议 -->\n  \u003Csection class=\"anti-cancer-guide-section\" style=\"background:linear-gradient(90deg, #f0f5fd 60%, #f6f9f3 100%);\">\n    \u003Ch2 class=\"anti-cancer-guide-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n      09 核心总结：靶向药/免疫药安全用药的总要点 📝\n    \u003C/h2>\n    \u003Cdiv class=\"anti-cancer-guide-text\">\n      靶向治疗和免疫治疗给患者带来了新的生机，但它们的用药细节和风险管理同样非常重要。\u003Cbr>\n      \u003Cb>简明观点：\u003C/b>\n      \u003Cul class=\"anti-cancer-guide-list\">\n        \u003Cli>永远不要随意自行增减剂量或停药\u003C/li>\n        \u003Cli>所有药品的服用方法、储存细节和常见副作用都要“上心”\u003C/li>\n        \u003Cli>用药时要主动告知医生自己使用的全部药品和补充剂\u003C/li>\n        \u003Cli>出现不明不适或反应时，及时与专业医护沟通\u003C/li>\n      \u003C/ul>\n      按照上述细节执行，可以显著提升药物安全性与疗效。如有疑惑，请及时寻求医生或药师帮助。身体健康，每一剂药都关乎安心。\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 参考文献 -->\n  \u003Csection class=\"anti-cancer-guide-section\" style=\"background:linear-gradient(90deg, #f7faf6 60%, #eef5fa 100%);\">\n    \u003Ch2 class=\"anti-cancer-guide-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n      参考文献与数据支持 📚\n    \u003C/h2>\n    \u003Cdiv class=\"anti-cancer-guide-text\">\n      \u003Col class=\"anti-cancer-guide-reflist\">\n        \u003Cli>\n          Shaw AT, Kim DW, Mehra R, et al. \"Ceritinib in ALK-rearranged non-small-cell lung cancer.\" New England Journal of Medicine, 2014, 370(13): 1189-1197. https://doi.org/10.1056/NEJMoa1311107\n        \u003C/li>\n        \u003Cli>\n          Paz-Ares L, Luft A, Vicente D, et al. \"Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung Cancer.\" New England Journal of Medicine, 2018; 379:2040-2051. https://doi.org/10.1056/NEJMoa1810865\n        \u003C/li>\n        \u003Cli>\n          Mok TS, Wu YL, Ahn MJ, et al. \"Osimertinib or Platinum–Pemetrexed in EGFR T790M–Positive Lung Cancer.\" New England Journal of Medicine, 2017; 376:629-640. https://doi.org/10.1056/NEJMoa1612674\n        \u003C/li>\n        \u003Cli>\n          Liu SV, Reck M, Mansfield AS, et al. \"Updated Integrated Analysis of the Safety of Alectinib in ALK-Positive Non–Small Cell Lung Cancer.\" Clinical Lung Cancer, 2021; 22(2):124-132. https://doi.org/10.1016/j.cllc.2020.08.005\n        \u003C/li>\n      \u003C/ol>\n      \u003Cp style=\"margin-top:8px;font-size:1em;color:#779;\">\u003Cbr>\u003C/p>\n    \u003C/div>\n  \u003C/section>\n\u003C/div>\n\n\u003Cstyle>\n.anti-cancer-guide-root {\n  max-width: 900px;\n  margin: 48px auto;\n  font-family: 'PingFang SC', 'Hiragino Sans GB', 'Arial', 'Helvetica', sans-serif;\n  color: #212a37;\n  background: #fafbfc;\n  border-radius: 12px;\n  box-shadow: 0 4px 24px rgba(165, 219, 188, 0.13);\n  padding: 28px 32px 40px 32px;\n  line-height: 1.9;\n}\n.anti-cancer-guide-banner {\n  text-align: left;\n  margin-bottom: 28px;\n}\n.anti-cancer-guide-banner h1 {\n  font-size: 2.2em;\n  font-weight: bold;\n  margin-top: 0;\n  margin-bottom: 12px;\n  color: #234fa1;\n  background: linear-gradient(90deg,#badeec 20%,#eafaf6 100%);\n  display: inline-block;\n  padding: 14px 20px 6px 20px;\n  border-radius: 10px;\n}\n.anti-cancer-guide-lead {\n  font-size: 1.15em;\n  color: #2a5946;\n  background: #eafaf6;\n  border-left: 6px solid #51c4a6;\n  border-radius: 6px;\n  padding: 10px 16px;\n  margin-bottom: 10px;\n  display: flex;\n  align-items: center;\n}\n.anti-cancer-guide-lead span:first-child {\n  font-size: 1.6em;\n  margin-right: 12px;\n}\n.anti-cancer-guide-section {\n  margin: 38px 0;\n  padding: 28px 22px 24px 22px;\n  border-radius: 10px;\n  box-shadow: 0 1px 6px 0 rgba(76, 125, 145, 0.07);\n  background-size: 240px 140px;\n  background-repeat: no-repeat;\n  background-position: right bottom;\n  /* 若需可用background-image嵌入淡色插画 */\n}\n.anti-cancer-guide-title {\n  font-size: 1.45em;\n  color: #3793e5;\n  padding-bottom: 3px;\n  font-weight: 600;\n  border-left: 6px solid #acebeb;\n  padding-left: 12px;\n  letter-spacing: .5px;\n}\n.anti-cancer-guide-text {\n  font-size: 1.08em;\n  color: #233b52;\n  margin: 15px 0 0 0;\n  padding-left: 3px;\n}\n.anti-cancer-guide-remark {\n  color: #2a9052;\n  font-weight: 600;\n  margin-top: 6px;\n  display: inline-block;\n}\n.anti-cancer-guide-list {\n  margin: 8px 0 4px 28px;\n  padding: 0;\n  list-style: disc outside;\n}\n.anti-cancer-guide-list li {\n  margin-bottom: 7px;\n  font-size: 1em;\n}\n.anti-cancer-guide-reflist {\n  font-size: 1em;\n  margin-left: 18px;\n  color: #4b5f71;\n}\n@media (max-width: 600px) {\n  .anti-cancer-guide-root { padding: 14px 6px 24px 6px; }\n  .anti-cancer-guide-section { padding: 14px 2px 16px 8px; }\n  .anti-cancer-guide-banner h1 { font-size: 1.2em; padding: 8px 7px 5px 8px;}\n  .anti-cancer-guide-lead { font-size: 1em; }\n}\n\u003C/style>\n","\u003Cdiv class=\"anti-cancer-guide-root\">\n  \u003Cdiv class=\"anti-cancer-guide-banner\">\n    \u003Ch2 id=\"material_t",519,"2025-09-12 11:30:28","肺癌治疗, 靶向药, 免疫药, 安全用药, 药物不良反应","了解靶向药和免疫药的作用机制、服用方法及不良反应，获取专业的安全用药指导，助力肺癌患者安全治疗与康复。","2025-09-17 15:08:14",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]